Jove
Visualize
Contáctanos

Videos de Conceptos Relacionados

Drug Dependence01:17

Drug Dependence

Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
CNS Depressants: Alcohol and Nicotine01:27

CNS Depressants: Alcohol and Nicotine

Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...
Drugs Acting on Autonomic Ganglia: Stimulants01:23

Drugs Acting on Autonomic Ganglia: Stimulants


Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Stimulants01:29

Stimulants

Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Stress Prevention and Stress Management Techniques IV01:26

Stress Prevention and Stress Management Techniques IV

Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Effects of relighting cigarettes on biomarkers of carcinogen and toxicant exposures.

Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco·2026
Same author

Cigarette relighting disparities and potential implications: Survey findings from a large US probability sample.

Addictive behaviors·2026
Same author

The impact of very low nicotine cigarettes on cannabis and alcohol use during a 12-week clinical trial.

Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco·2026
Same author

Changes in the Oral Microbiota after Switching from Smoking to Exclusive e-Cigarette Use in an 8-Week Product-Switching Trial.

Cancer prevention research (Philadelphia, Pa.)·2026
Same author

Titration of nicotine intake in smokers switching to reduced nicotine content cigarettes with access to alternative nicotine systems: Secondary analysis of a randomized clinical trial.

Addiction (Abingdon, England)·2026
Same author

A watercress drink increases detoxification of common environmental carcinogens such as acrolein and benzene: results of a randomized clinical trial.

Carcinogenesis·2026
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Video Experimental Relacionado

Updated: Jul 4, 2026

Creating Dynamic Images of Short-lived Dopamine Fluctuations with lp-ntPET: Dopamine Movies of Cigarette Smoking
14:21

Creating Dynamic Images of Short-lived Dopamine Fluctuations with lp-ntPET: Dopamine Movies of Cigarette Smoking

Published on: August 6, 2013

Adicción al tabaco adicción al tabaco

Dorothy K Hatsukami1, Lindsay F Stead, Prakash C Gupta

  • 1University of Minnesota, Comprehensive Cancer Center and Psychiatry, Minneapolis, Minnesota, USA. hatsu001@umn.edu

Lancet (London, England)
|June 17, 2008
PubMed
Resumen

La adicción al tabaco causa millones de muertes al año. Los programas y tratamientos efectivos de control del tabaco son cruciales, pero las altas tasas de recaída resaltan la nicotina.

Área de la Ciencia:

  • Salud Pública La salud pública.
  • Medicina de la adicción Medicina de la adicción
  • Ciencias del comportamiento Ciencias del comportamiento.

Sus antecedentes:

  • El consumo de tabaco es una de las principales causas mundiales de muerte prematura, responsable de 5 millones de muertes al año.
  • Los programas integrales de control del tabaco son esenciales para reducir la prevalencia del consumo de tabaco.
  • Abordar la adicción al tabaco requiere enfocar los aspectos neurobiológicos y conductuales.

Objetivo del estudio:

  • Para resaltar la importancia del tratamiento para la adicción al tabaco dentro de los programas de control integral.
  • Discutir las estrategias de tratamiento actuales y sus limitaciones.
  • Explorar las direcciones futuras para mejorar el tratamiento de la adicción a la nicotina.

Principales métodos:

Más Videos Relacionados

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations
09:25

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations

Published on: January 10, 2015

Videos de Experimentos Relacionados

Last Updated: Jul 4, 2026

Creating Dynamic Images of Short-lived Dopamine Fluctuations with lp-ntPET: Dopamine Movies of Cigarette Smoking
14:21

Creating Dynamic Images of Short-lived Dopamine Fluctuations with lp-ntPET: Dopamine Movies of Cigarette Smoking

Published on: August 6, 2013

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations
09:25

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations

Published on: January 10, 2015

  • Revisión de la literatura existente sobre la adicción al tabaco, las modalidades de tratamiento y las tasas de éxito de cesación.
  • Análisis de los factores neurobiológicos y conductuales que contribuyen a la adicción a la nicotina.
  • Examen de la infraestructura del sistema de salud y la accesibilidad al tratamiento.

Principales resultados:

  • Los tratamientos farmacológicos y conductuales mejoran el éxito del cese, pero las tasas de recaída siguen siendo altas.
  • La adicción a la nicotina se caracteriza por una fuerte naturaleza adictiva.
  • La infraestructura actual y la accesibilidad de los tratamientos necesitan mejorar.

Conclusiones:

  • El tratamiento eficaz de la adicción al tabaco requiere un enfoque multifacético.
  • Las futuras estrategias deben centrarse en la adecuación personalizada del tratamiento al paciente, las terapias combinadas y los nuevos medicamentos.
  • Es fundamental ver la adicción a la nicotina como un trastorno crónico que requiere un manejo a largo plazo.